Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.25 USD | 0.00% | +1.63% | +2.46% |
2023 | Global Cord Blood Corporation Announces Board Appointments | CI |
2023 | Global Cord Blood Corporation(NYSE:CO) dropped from S&P Global BMI Index | CI |
Sales 2021 | 1.16B 160M | Sales 2022 | 1.24B 172M | Capitalization | 2.97B 410M |
---|---|---|---|---|---|
Net income 2021 | 508M 70.19M | Net income 2022 | 501M 69.23M | EV / Sales 2021 | -2.13 x |
Net cash position 2021 | 6.07B 839M | Net cash position 2022 | 6.66B 920M | EV / Sales 2022 | -2.97 x |
P/E ratio 2021 |
7.1
x | P/E ratio 2022 |
5.93
x | Employees | 1,202 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 38.41% |
3 months | -37.50% | ||
Current year | +2.46% |
Managers | Title | Age | Since |
---|---|---|---|
Ting Zheng
CEO | Chief Executive Officer | 52 | 08-12-31 |
Bing Chuen Chen
DFI | Director of Finance/CFO | 48 | 08-12-31 |
Xin Xu
CTO | Chief Tech/Sci/R&D Officer | 70 | 04-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jennifer J. Weng
BRD | Director/Board Member | 56 | 08-12-31 |
Ting Zheng
CEO | Chief Executive Officer | 52 | 08-12-31 |
Director/Board Member | 56 | 08-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-14 | 1.25 | 0.00% | 1 651 |
24-05-13 | 1.25 | 0.00% | 6,153 |
24-05-10 | 1.25 | +1.63% | 7,890 |
24-05-09 | 1.23 | -1.60% | 4,300 |
Delayed Quote OTC Markets, May 13, 2024 at 01:45 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+2.46% | 167M | |
+17.18% | 83.07B | |
-28.48% | 70.89B | |
+6.76% | 28.32B | |
-7.44% | 17.73B | |
+2.14% | 17.43B | |
+2.10% | 15.64B | |
+7.02% | 13.46B | |
+64.96% | 12.69B | |
+6.64% | 12.82B |
- Stock Market
- Equities
- CORBF Stock